Clinical significance of hormonal receptor status of malignant ovarian tumors

Clinical significance of hormonal receptor status of malignant ovarian tumors

Objectives: To study hormonal receptor status (HRS) of malignant ovarian tumors (MOT) and determine its clinical significance. Patients and Methods: Retrospective analysis of case histories of 284 patients with MOT of different genesis of I–IV stages was carried out; immunohistochemical study of par...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental Oncology
Datum:	2014
Hauptverfasser:	Tkalia, I.G., Vorobyova, L.I., Svintsitsky, V.S., Nespryadko, S.V., Goncharuk, I.V., Lukyanova, N.Y., Chekhun, V.F.
Format:	Artikel
Sprache:	English
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2014
Schlagworte:	Original contributions
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/145343
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Clinical significance of hormonal receptor status of malignant ovarian tumors / I.G. Tkalia, L.I. Vorobyova, V.S. Svintsitsky, S.V. Nespryadko, I.V. Goncharuk, N.Y. Lukyanova, V.F. Chekhun // Experimental Oncology. — 2014. — Т. 36, № 2. — С. 125-133. — Бібліогр.: 39 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: I. G. Tkalia, et al.
Veröffentlicht: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: I. G. Tkalia, et al.
Veröffentlicht: (2014)

Recurrence of borderline ovarian tumors
von: V. S. Svintsitskiy, et al.
Veröffentlicht: (2013)

Recurrence of borderline ovarian tumors
von: Svintsitskiy, V.S., et al.
Veröffentlicht: (2013)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
von: Buchynska, L.G., et al.
Veröffentlicht: (2009)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
von: Tkalia, I.G., et al.
Veröffentlicht: (2015)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

General clinical, biochemical parameters and peripheral blood hormone level in women at ovarian hyperstimulation syndrome
von: N. V. Avramenko, et al.
Veröffentlicht: (2018)

Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
von: N. P. Yurchenko, et al.
Veröffentlicht: (2020)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
von: I. G. Tkalia, et al.
Veröffentlicht: (2015)

Clinical significance of estrogen receptor gene ERS1 SNP in cancer patients from families with oncological pathology in pedigrees
von: Paliychuk, O.V, et al.
Veröffentlicht: (2016)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: S. V. Chekhun, et al.
Veröffentlicht: (2014)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
von: V. F. Chekhun, et al.
Veröffentlicht: (2017)

Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
von: Shyian, M., et al.
Veröffentlicht: (2011)

Cytomegaloviruses and malignant brain tumors
von: Lisyany, N.I., et al.
Veröffentlicht: (2023)

Ovarian cancer: family cancer syndrome and clinical significance of testing of the mutations in BRCA1 and BRCA2?genes
von: O. V. Paliichuk, et al.
Veröffentlicht: (2016)

Expression of galectin-1 in malignant tumors
von: Demydenko, D., et al.
Veröffentlicht: (2009)

Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2018)

Relationship between malignant tumor metabolism and tumor-bearing organism
von: T. N. Popovskaja, et al.
Veröffentlicht: (2019)

Hormonal impact on tumor growth and progression
von: A. Reznikov
Veröffentlicht: (2015)

Hormonal impact on tumor growth and progression
von: Reznikov, A.
Veröffentlicht: (2015)

Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
von: O. V. Ponomareva
Veröffentlicht: (2018)

Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
von: Chekhun, V.F., et al.
Veröffentlicht: (2009)

Clinical hormonal characteristics and therapy of girls with endometrial hyperplasia and anemia
von: I. A. Tuchkina, et al.
Veröffentlicht: (2014)

Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
von: Zalutski, I.V., et al.
Veröffentlicht: (2017)

Vacuum cryo-thermal probe for destruction of malignant tumors
von: M. I. Gasanov, et al.
Veröffentlicht: (2013)

Protein and carbohydrate metabolism disorders in patients with malignant tumors of the intestine
von: T. N. Popovskaja, et al.
Veröffentlicht: (2018)

The peculiarities of ultra sound diagnostics of borderline ovarian tumors
von: E. S. Klimenko, et al.
Veröffentlicht: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
von: S. V. Vtorushin, et al.
Veröffentlicht: (2014)

The phenomenon of multi-drug resistance in the treatment of malignant tumors
von: Vtorushin, S.V., et al.
Veröffentlicht: (2014)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
von: Bubnovskaya, L., et al.
Veröffentlicht: (2012)

Genetic and epigenetic changes in malignant cells of tumors of urogenital organs
von: Gordiyuk, V.V.
Veröffentlicht: (2010)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

Clinical features of patients with syndrome of biologically inactive growth hormone
von: N. A. Sprynchuk
Veröffentlicht: (2019)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
von: O. D. Ryabtseva, et al.
Veröffentlicht: (2013)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
von: Ryabtseva, O.D., et al.
Veröffentlicht: (2013)

Anti-Muller hormone detection and Doppler study of ovary blood supply in diagnosis of poor ovarian response syndrome
von: V. A. Pitko, et al.
Veröffentlicht: (2013)

Laboratory parameters as predictors of bladder tumor malignancy grade
von: L. A. Derzhavets
Veröffentlicht: (2013)